Clinical trial · Interventional
eHealth Support Tool to Improve Quality of Life in Head and Neck Cancer Survivors
NCT07426874CI-TRIAL-00103859active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. The intervention integrates symptom monitoring, self-management education, and structured survivorship support into routine follow-up care. Outcomes will include patient-reported quality of life, symptom burden, and healthcare utilization.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer (H&N) | Malignant Head and Neck Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control | Other | — | UNRESOLVED |
| eHealth Survivorship Support Tool | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Intervention Name: eHealth Survivorship Support Tool Description: A digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up
- interventionNames
- Other: eHealth Survivorship Support Tool
- type
- ACTIVE_COMPARATOR
- label
- Control
- description
- Participants receive standard survivorship follow-up as per institutional guidelines.
- interventionNames
- Other: Control
Primary outcomes (1)
- measure
- Quality of Life EORTC QLQ-C30 (Global Health Status scale)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Adults ≥18 years Diagnosed with head and neck cancer Completed primary treatment (surgery, radiotherapy, chemotherapy or combination) Within 12 months post-treatment Access to smartphone/tablet/internet Able to provide informed consent Exclusion Criteria: Recurrent or metastatic disease requiring active treatment Significant cognitive impairment Inability to use digital device Non-English speakers (if tool not multilingual)
References
Publications (0)
Data not yet available
No reference posted for this study.